The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector
Life science M&A transaction value distribution in China 2018, by sector
Pharma sector has become more popular for mergers and acquisitions (M&A) in China. In 2018, the drug sector accounted for ** percent of the total transaction value of the M&A activities in the Chinese life science industry.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Value of mergers and acquisitions (M&A) deals in China healthcare 2012-2021
- Premium Statistic Share of VC investment in China's life science industry 2021, by sector
- Premium Statistic Cross-border venture capital investment in China's life science 2021, by company
- Premium Statistic VC and PE investment in China healthcare 2012-2021
- Premium Statistic VC and PE funds raised targeting China healthcare 2012-2021
- Premium Statistic Life science investment estimated growth rate in China 2021, by type
- Premium Statistic Key figures of life science investment in China 2008-2021
- Premium Statistic Mainland China investment in health and social work services in Taiwan 2014-2024
- Premium Statistic Primary market investments in China's healthcare industry 2009-2019, by sector
- Premium Statistic Healthcare VC exit value in China 2007-2018
About the region
10
- Premium Statistic Largest company takeovers with Chinese involvement in 2019, by transaction value
- Premium Statistic Cross border LSHC M&A deal volume in China 2018-2020, by target sub-sector
- Premium Statistic Chinese outbound M&A deal value in Belt and Road countries 2015-2019
- Premium Statistic Quarterly value and number of LSHC merger and acquisition deals in China 2019-2021
- Premium Statistic Transaction value of foreign company takeovers by Chinese companies 2022
- Premium Statistic Number of financial pharmaceutical deals in China 2016-2019, by type
- Premium Statistic Chinese outbound M&A deal volume in Belt and Road countries 2015-2019
- Premium Statistic Foreign partnership in China's pharma industry 2013-2021
- Premium Statistic Number of investment deals of strategic buyers in Chinese biotechnology 2016-2019
- Premium Statistic Annual FDI flows from China to South Korea 2014-2024
Selected statistics
10
- Premium Statistic COVID-19 control measures' impact on U.S. companies' business plans in China 2022
- Premium Statistic Number of investments in the HealthTech sector in Poland 2019-2024
- Premium Statistic HealthTech sector transaction value in Poland 2019-2024
- Premium Statistic Top impacts of COVID control measures on U.S. companies' business plans in China 2022
- Premium Statistic Healthcare sector M&A deal value Singapore 2023-2024
- Premium Statistic Geographical distribution of medical aesthetics customers in China 2020
- Premium Statistic Physical traits important to medical aesthetics consumers in China 2020
- Premium Statistic Chinese consumers' awareness of the source of medical aesthetic products 2022
- Premium Statistic Estimated value of investment plans in U.S. companies affected by COVID in China 2022
- Premium Statistic Healthcare private investment Asia 2019-2024, by segment
Other regions
10
- Premium Statistic M&A deal number in the medical device sector in China 2014-2020, by region
- Premium Statistic Leading inbound M&A investing countries in Vietnam 2010-2020, by deal value
- Basic Statistic Number of M&A healthcare deals in California and the U.S. in 2021, by sector
- Premium Statistic Largest healthcare M&A deals worldwide H1 2025
- Basic Statistic Quarterly M&A in the U.S. in healthcare and life sciences sector 2018-2021
- Basic Statistic Value of M&As in the U.S. healthcare and life sciences sector 2009-2021
- Premium Statistic EV/EBITDA in the health & pharmaceuticals sector in Europe 2019-2026, by industry
- Premium Statistic Financial advisors ranked by M&A deal count in Norway 2023
- Premium Statistic Main reasons why M&A transactions fail to generate expected value in the US 2019
- Premium Statistic Leading factors in achieving a successful M&A deal in the United States 2019
Related statistics
10
- Premium Statistic Annual FDI flows from China to Japan 2014-2024
- Premium Statistic Annual FDI flows from China to Indonesia 2014-2024
- Premium Statistic Total value of top pharmaceutical venture financing deals 2014
- Premium Statistic Chinese pharmaceutical M&A deal value from strategic buyers 2016-2019, by region
- Premium Statistic Chinese outbound investment deal value in pharmaceuticals 2016-2019, by type
- Premium Statistic Chinese pharmaceutical M&A deal value from financial buyers 2016-2019, by type
- Basic Statistic Largest biotech financing deals in the United States in Q4 2020, by company
- Premium Statistic Biopharma companies with market-ready connected health products worldwide 2021-2024
- Premium Statistic Largest digital health seed/angel deals worldwide in Q3 2025
- Premium Statistic Areas biopharma companies focus on with connected health worldwide 2021-2024
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
ChinaBio. (January 6, 2019). Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. "Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector ." Chart. January 6, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. (2019). Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio. "Share of The Merger and Acquisition Deal Value in The Life Science Industry in China in 2018, by Sector ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 6 Jan 2019, /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
ChinaBio, Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector ÌÇÐÄÆƽâ°æ, /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/ (last visited July 29, 2026)
Share of the merger and acquisition deal value in the life science industry in China in 2018, by sector [Graph], ChinaBio, January 6, 2019. [Online]. Available: /statistics/1075432/china-life-science-merger-and-acquisition-deal-value-breakdown-by-sector/
Advertisement